Research of Burden of Interstititial Lung Diseases in Turkey

• Conditions: Lung Diseases, Interstitial; Fibrosis Lung

• Registration Number: NCT03995654
• Lead Sponsor: Karadeniz Technical University

Brief Summary

The aim of our study is to investigate the etiological distribution of ILD, epidemiological characteristics of ILD cases such as age, gender, geography, smoking, occupation, economic status, education, and comorbidities. Another aim is to make the cost calculation from the first to the diagnosis in the patients diagnosed. Obtaining the missing data related to the ILD of our country is one of our goals.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-01
• Study First Submitted: 2019-05-30
• Study First Submitted QC: 2019-06-19
• Study First Posted: 2019-06-24
• Status Verified: 2021-03
• Last Update Submitted: 2021-03-04
• Last Update Posted: 2021-03-05
• Primary Completion: 2021-04-01
• Study Completion: 2021-05-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

• Patients who are not previously diagnosed with ILD will be included in the study.

Exclusion Criteria

• under 18 years old
• older 80 years old

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Etiological distribution	1 year	Geographic distribution of ILD patients according to regions (will be presented as %)
Epidemiological characteristics of ILD cases	1 year	Distiribution of ILD patienst according to comorbidities (will be presented as YES or NO and %) Comorbiditites are; Hypertension, Heart failure, Coronary Artery Disease, Arrhythmia, Heart Valve Disease, Asthma, COPD, Chronic Renal Disease, Diabetes Mellitus, Hyper / Hypothyroidism, HIV, Cirrhosis / Chronic Liver Disease, Lung malignancy, Extrapulmonary solid organ malignancy, Hematologic malignancy, SVO, Alzeimer, Epilepsy, Neuromuscular Ill, Organ Transplant Receiver, Reflux, Slyding hernia, Others
Total number	1 year	We planned enroll roughly 1000 patients to the study

Secondary Outcome Measures

Name	Time	Method
Clinical findings	1year	According to the etiology of ILD, clinical findings (Rod, Ral, Rash, Arthritis, Alopecia, Erythema nodosum, Peripheral lymphadenomegaly, Cyanosis, Edema, Raynaud's phenomenon, Other) will be presented as YES or NO and %
Pulmonary functions	1year	According to the etiology of ILD, pulmonary functions, will be assessed; PaO2 with Pulse oximeter (%)
Time	1year	According to the etiology of ILD, the time spent for diagnosis will be presented Time will be presented as months.
Treatment methods	1year	Determining the treatment preferences of physicians according to the etiology of the cases will be presented; Treatment methods are; Non-treatment monitoring, Symptomatic treatment, Systemic corticosteroid, Cytostatic drugs, Antifibrosan drugs (eg Pirfenidone, Nintedanib), Immunological therapy, Referral to other centers, Preparing for transplantation, Home oxygen therapy, Reflux therapy, Other (Methods are will be shown as YES or NO and %)
Diagnostic methods	1year	According to the etiology of ILD, diagnostic methods used in ILD cases will be presented Diagnoses methods are; Clinical and radiology, Bronchoscopic transbronchial lung biopsy, Bronchoalveolar lavage, Transthoracic needle biopsy with imaging, EBUS, VATS, Thoracotomy, Other (Methods are will be shown as YES or NO and %)

Trial Locations

Locations (1)

Department Of Chest Diseases, School Of medicine, Karadeniz Technical University; 🇹🇷 Trabzon, Turkey